Idhifa and Hypotension - a phase IV clinical study of FDA data

Summary:

Hypotension is reported as a side effect among people who take Idhifa (enasidenib mesylate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ondansetron, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Hypotension when taking Idhifa. It is created by eHealthMe based on reports of 2,880 people who have side effects when taking Idhifa from the FDA, and is updated regularly.

What is Idhifa?

Idhifa has active ingredients of enasidenib mesylate. eHealthMe is studying from 2,880 Idhifa users. Check the latest studies of Idhifa.

What is Hypotension?

Hypotension (abnormally low blood pressure) is found to be associated with 3,361 drugs and 4,754 conditions by eHealthMe. Check the latest studies of Hypotension.

On Jul, 13, 2026

2,880 people reported to have side effects when taking Idhifa.
Among them, 21 people (0.73%) have Hypotension.

Among these 21 people:

How long have people been on Idhifa when they have Hypotension? *

What is the gender of people who have Hypotension when taking Idhifa? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Hypotension when taking Idhifa? *

What are other drugs people take besides Idhifa? *

What are other side effects people have besides Hypotension? *

Dizziness: 4 people, 19.05%
Full Blood Count Decreased: 3 people, 14.29%
Weakness: 3 people, 14.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 2 people, 9.52%
Red Blood Cell Count Decreased: 2 people, 9.52%
Blood Potassium Decreased: 2 people, 9.52%
Pneumonia: 2 people, 9.52%
Weight Increased: 2 people, 9.52%
Fever: 2 people, 9.52%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 16 people, 76.19%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 9.52%
Essential Hypertension (primary hypertension): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Idhifa and have Hypotension?

- Check whether Hypotension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Idhifa:

Idhifa (2,880 reports)

Hypotension treatments and more:

Hypotension (329,856 reports)

Browse all side effects of Idhifa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypotension:

Hypotension (3,361 drugs)

Browse all the conditions that are associated with Hypotension:

Hypotension (4,754 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enasidenib mesylate (the active ingredients of Idhifa) and Idhifa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.